132.66
price down icon3.42%   -4.70
pre-market  プレマーケット:  132.99   0.33   +0.25%
loading
前日終値:
$137.36
開ける:
$137.06
24時間の取引高:
8.51M
Relative Volume:
1.51
時価総額:
$230.08B
収益:
$41.95B
当期純損益:
$13.40B
株価収益率:
17.34
EPS:
7.65
ネットキャッシュフロー:
$6.35B
1週間 パフォーマンス:
-3.58%
1か月 パフォーマンス:
+0.93%
6か月 パフォーマンス:
+13.77%
1年 パフォーマンス:
+10.38%
1日の値動き範囲:
Value
$132.31
$137.06
1週間の範囲:
Value
$132.31
$139.15
52週間の値動き範囲:
Value
$99.71
$140.84

Abbott Laboratories Stock (ABT) Company Profile

Name
名前
Abbott Laboratories
Name
セクター
Healthcare (1170)
Name
電話
(224) 667-6100
Name
住所
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
Name
職員
114,000
Name
Twitter
@AbbottNews
Name
次回の収益日
2025-01-22
Name
最新のSEC提出書
Name
ABT's Discussions on Twitter

ABT を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Medical Devices icon
ABT
Abbott Laboratories
132.66 230.08B 41.95B 13.40B 6.35B 7.65
Medical Devices icon
BSX
Boston Scientific Corp
95.52 140.97B 16.75B 1.85B 2.37B 1.25
Medical Devices icon
SYK
Stryker Corp
365.29 139.39B 22.60B 2.99B 3.49B 7.76
Medical Devices icon
MDT
Medtronic Plc
93.28 119.61B 33.20B 4.26B 5.47B 3.29
Medical Devices icon
EW
Edwards Lifesciences Corp
68.39 40.21B 5.72B 4.17B 259.90M 6.97

Abbott Laboratories Stock (ABT) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-10-08 開始されました Oppenheimer Outperform
2024-09-19 開始されました Piper Sandler Overweight
2024-07-30 ダウングレード Edward Jones Buy → Hold
2024-05-30 開始されました Goldman Buy
2023-07-21 アップグレード Wolfe Research Underperform → Peer Perform
2023-05-30 ダウングレード Morgan Stanley Overweight → Equal-Weight
2023-04-20 繰り返されました Barclays Overweight
2023-04-20 繰り返されました Bernstein Outperform
2023-04-20 繰り返されました JP Morgan Overweight
2023-04-20 繰り返されました Raymond James Outperform
2023-04-20 繰り返されました UBS Buy
2023-04-20 繰り返されました Wolfe Research Underperform
2023-03-29 開始されました UBS Buy
2022-10-26 開始されました Mizuho Neutral
2022-10-18 開始されました Barclays Overweight
2022-10-12 開始されました Jefferies Hold
2022-07-06 開始されました Wolfe Research Underperform
2022-03-02 再開されました BofA Securities Buy
2022-01-27 繰り返されました Credit Suisse Outperform
2022-01-27 繰り返されました Morgan Stanley Overweight
2022-01-27 繰り返されました Raymond James Outperform
2022-01-27 繰り返されました UBS Buy
2021-12-10 開始されました RBC Capital Mkts Outperform
2021-10-27 アップグレード Atlantic Equities Neutral → Overweight
2021-10-14 開始されました Redburn Neutral
2021-05-25 開始されました Barclays Overweight
2021-04-15 開始されました Atlantic Equities Neutral
2021-01-28 アップグレード BTIG Research Neutral → Buy
2020-09-11 開始されました Wolfe Research Outperform
2020-06-01 ダウングレード Goldman Neutral → Sell
2020-03-05 開始されました Citigroup Buy
2020-02-13 開始されました Goldman Neutral
2020-02-06 再開されました BTIG Research Neutral
2020-01-02 ダウングレード Guggenheim Buy → Neutral
2019-06-13 繰り返されました BofA/Merrill Buy
2019-02-07 繰り返されました BofA/Merrill Buy
2019-01-02 ダウングレード Citigroup Neutral → Sell
2018-11-30 アップグレード Goldman Neutral → Buy
2018-10-16 開始されました Barclays Overweight
2018-06-27 開始されました Bernstein Outperform
2018-01-30 繰り返されました Citigroup Neutral
2018-01-25 繰り返されました Stifel Buy
2018-01-25 アップグレード William Blair Mkt Perform → Outperform
2018-01-03 開始されました Evercore ISI Outperform
2018-01-02 アップグレード JP Morgan Neutral → Overweight
2018-01-02 アップグレード Morgan Stanley Equal-Weight → Overweight
2017-10-19 繰り返されました RBC Capital Mkts Outperform
2017-10-19 繰り返されました Stifel Buy
すべてを表示

Abbott Laboratories (ABT) 最新ニュース

pulisher
Mar 11, 2025

OTC Consumer Health Market Positioned for Accelerated Growth with Johnson&Johnson, Abbott Laboratories, - EIN News

Mar 11, 2025
pulisher
Mar 11, 2025

Breast Cancer Diagnostics Market Set for 6.9% CAGR Growth, projected to Hit USD 12.45 Billion by 2035 - GlobeNewswire Inc.

Mar 11, 2025
pulisher
Mar 11, 2025

Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know - Nasdaq

Mar 11, 2025
pulisher
Mar 11, 2025

Neurological Biomarkers: Global Market Review 2020-2024 and - GlobeNewswire

Mar 11, 2025
pulisher
Mar 11, 2025

Abbott Laboratories (NYSE:ABT) Given New $150.00 Price Target at Bank of America - Defense World

Mar 11, 2025
pulisher
Mar 10, 2025

Abbott Laboratories Options Trading: A Deep Dive into Market Sentiment - Benzinga

Mar 10, 2025
pulisher
Mar 10, 2025

BofA Raises Price Target on Abbott Laboratories to $150 From $133 -March 10, 2025 at 10:06 am EDT - Marketscreener.com

Mar 10, 2025
pulisher
Mar 10, 2025

Electroceutical Devices Market Projected To Witness Substantial Growth, 2025-2032: Medtronic plc, Abbott - EIN News

Mar 10, 2025
pulisher
Mar 10, 2025

Abbott Laboratories Stock Analysis: Short-Term Gains vs. Long-Term ChallengesNews and Statistics - IndexBox, Inc.

Mar 10, 2025
pulisher
Mar 10, 2025

3 Reasons to Avoid ABT and 1 Stock to Buy Instead - Yahoo Finance

Mar 10, 2025
pulisher
Mar 10, 2025

Cancer Diagnostics Market Top PlayersGE Healthcare, Abbott - openPR

Mar 10, 2025
pulisher
Mar 10, 2025

Shedd Aquarium receives $10 million pledge from Abbott - Philanthropy News Digest

Mar 10, 2025
pulisher
Mar 08, 2025

ServiceNow, Abbott, Chipotle, Archer, T-Mobile Stock Shakeup! - TipRanks

Mar 08, 2025
pulisher
Mar 08, 2025

Estimating The Fair Value Of Abbott Laboratories (NYSE:ABT) - Yahoo Finance

Mar 08, 2025
pulisher
Mar 08, 2025

Abbott Labs sued for alleged ADA, human rights and whistleblower protection violations - Press Herald

Mar 08, 2025
pulisher
Mar 07, 2025

Top Executive Cashes In on Abbott Laboratories Stock! - TipRanks

Mar 07, 2025
pulisher
Mar 07, 2025

Abbott Laboratories EVP Lisa Earnhardt sells $12.2m in stock - Investing.com

Mar 07, 2025
pulisher
Mar 07, 2025

Japan In-Vitro Diagnostics Market Forecast Report and - GlobeNewswire

Mar 07, 2025
pulisher
Mar 07, 2025

Strong Earnings Lift Abbott Laboratories Shares - FX Empire

Mar 07, 2025
pulisher
Mar 06, 2025

Citigroup Forecasts Strong Price Appreciation for Abbott Laboratories (NYSE:ABT) Stock - Defense World

Mar 06, 2025
pulisher
Mar 05, 2025

Invest with Confidence: Intrinsic Value Unveiled of Abbott Labor - GuruFocus.com

Mar 05, 2025
pulisher
Mar 05, 2025

Insider Sell: Andrea Wainer Sells Shares of Abbott Laboratories (ABT) - GuruFocus.com

Mar 05, 2025
pulisher
Mar 05, 2025

Cadrenal and Abbott sign agreement for LVAD trial of tecarfarin - Medical Device Network

Mar 05, 2025
pulisher
Mar 05, 2025

Padeiatricans’ summit sponsored by infant formula maker in violation of law - The Times of India

Mar 05, 2025
pulisher
Mar 05, 2025

Bioelectric Medicine Market Top Companies Study- Abbott - openPR

Mar 05, 2025
pulisher
Mar 05, 2025

Abbott Laboratories (NYSE:ABT) Hits New 12-Month High on Analyst Upgrade - Defense World

Mar 05, 2025
pulisher
Mar 05, 2025

Drug Testing Market Is Booming Worldwide 2025-2032 | Abbott - openPR

Mar 05, 2025
pulisher
Mar 04, 2025

Abbott Laboratories VP John McCoy Jr. sells $77,651 in stock By Investing.com - Investing.com South Africa

Mar 04, 2025
pulisher
Mar 04, 2025

Abbott Laboratories SVP Eric Shroff sells $77,651 in stock - Investing.com

Mar 04, 2025
pulisher
Mar 04, 2025

Abbott Laboratories retired EVP Andrea Wainer sells $131,123 in stock - Investing.com

Mar 04, 2025
pulisher
Mar 04, 2025

Abbott Laboratories EVP Louis Morrone sells $153,506 in shares - Investing.com India

Mar 04, 2025
pulisher
Mar 04, 2025

Abbott Laboratories EVP Mary Moreland sells shares worth $109,292 - Investing.com

Mar 04, 2025
pulisher
Mar 04, 2025

Abbott Laboratories VP John McCoy Jr. sells $77,651 in stock - Investing.com

Mar 04, 2025
pulisher
Mar 04, 2025

Healthcare Stocks Fall, Led Lower by SuppliersHealthcare Roundup -March 04, 2025 at 05:07 pm EST - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

IRS Asks To Toss Abbott Labs' FOIA Action For Tax Records - Law360

Mar 04, 2025
pulisher
Mar 04, 2025

Cognitive Enhancement Wearable Technology Patent Landscape - GlobeNewswire

Mar 04, 2025
pulisher
Mar 04, 2025

Where Abbott Laboratories Stands With Analysts - Benzinga

Mar 04, 2025
pulisher
Mar 04, 2025

Abbott Laboratories (NYSE:ABT) Partners With Cadrenal Therapeutics For TECH-LVAD Trial In Growing US$2B LVAD Market - Simply Wall St

Mar 04, 2025
pulisher
Mar 04, 2025

Here's why Jim Cramer disagrees with latest Wall Street call on Abbott Labs - CNBC

Mar 04, 2025
pulisher
Mar 04, 2025

He Fought Claims of Harm From Infant Formula. Now He Regulates It. - The New York Times

Mar 04, 2025
pulisher
Mar 04, 2025

Patent Foramen Ovale Closure Devices Market is Booming - openPR

Mar 04, 2025
pulisher
Mar 04, 2025

Cognitive Enhancement Wearable Technology Patent Landscape Report, 2017-2023 & 2024-2032 with Patent Profiles of Abbott Laboratories, IBM, Nestec, University of California, and Koninkl Philips Electronics - Yahoo Finance

Mar 04, 2025
pulisher
Mar 04, 2025

Cadrenal partners with Abbott for heart device trial - Investing.com India

Mar 04, 2025
pulisher
Mar 04, 2025

Can Cadrenal's Tecarfarin Revolutionize Treatment for HeartMate 3 LVAD Patients? - StockTitan

Mar 04, 2025
pulisher
Mar 04, 2025

Drug Eluting Stents Market Is Booming So Rapidly: Abbott Laboratories, Boston Scientific Corporation - openPR

Mar 04, 2025
pulisher
Mar 04, 2025

Is Abbott Laboratories' (NYSE:ABT) Stock's Recent Performance Being Led By Its Attractive Financial Prospects? - Yahoo Finance

Mar 04, 2025
pulisher
Mar 04, 2025

Goldman Sachs Adjusts Price Target on Abbott Laboratories to $154 From $138, Keeps Buy Rating - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

Gastritis Treatment Market Deep Research 2025-2032 | Abbott Laboratories, AstraZeneca PLC - openPR

Mar 04, 2025
pulisher
Mar 04, 2025

A secretary turned $180 into $7.2 million by holding her employer's stock for 75 years - AOL

Mar 04, 2025
pulisher
Mar 03, 2025

Is Abbott Laboratories Stock Outperforming the Dow? - Nasdaq

Mar 03, 2025
pulisher
Mar 03, 2025

Abbott Laboratories Reaches Analyst Target Price - Nasdaq

Mar 03, 2025

Abbott Laboratories (ABT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
medical_devices BSX
$95.52
price up icon 1.48%
medical_devices SYK
$365.29
price down icon 1.30%
medical_devices MDT
$93.28
price down icon 0.55%
medical_devices EW
$68.39
price down icon 0.20%
$85.59
price up icon 0.27%
大文字化:     |  ボリューム (24 時間):